Functional differentiation between rep-mediated site-specific integration and transcriptional repression of the adeno-associated viral p5 promoter

Human Gene Therapy

Volumn 21, Issue 6, 2010, Pages 728-738

  Yue, Yang Bo ^a   Xue, Yuan Yuan ^a   Tian, Ling ^a   Xue, Jing Lun ^a   Chen, Jin Zhong ^a   Jia, William ^a,b  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HELICASE; NUCLEOTIDE; TRANSCRIPTION FACTOR YY1;

ADENO ASSOCIATED VIRUS; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CYTOTOXICITY; GENE MUTATION; GENE THERAPY; NONHUMAN; POINT MUTATION; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN MOTIF; TATA BOX;

BASE SEQUENCE; DEPENDOVIRUS; GENE EXPRESSION; GENOME, VIRAL; HUMANS; PROTEIN BINDING; REGULATORY SEQUENCES, NUCLEIC ACID; TATA BOX;

ADENO-ASSOCIATED VIRUS;

EID: 77954989063     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2009.192     Document Type: Article

References (48)

1. Beaton, A., Palumbo, P., and Berns, K.I. (1989). Expression from the adeno-associated virus p5 and p19 promoters is negatively regulated in trans by the Rep protein. J. Virol. 63, 4450-4454.
2. Berthet, C., Raj, K., Saudan, P., and Beard, P. (2005). How adeno-associated virus Rep78 protein arrests cells completely in S phase. Proc. Natl. Acad. Sci. U.S.A. 102, 13634-13639.
3. Blacklow, N.R., Hoggan, M.D., Sereno, M.S., Brandt, C.D., Kim, H.W., Parrott, R.H., and Chanock, R.M. (1971). A ser-oepidemiologic study of adenovirus-associated virus infection in infants and children. Am. J. Epidemiol. 94, 359-366.
4. Chiorini, J.A., Yang, L., Safer, B., and Kotin, R.M. (1995). Determination of adeno-associated virus Rep68 and Rep78 binding sites by random sequence oligonucleotide selection. J. Virol. 69, 7334-7338.
5. Chiorini, J.A., Zimmermann, B., Yang, L., Smith, R.H., Ahearn, A., Herberg, F., and Kotin, R.M. (1998). Inhibition of PrKX, a novel protein kinase, and the cyclic AMP-dependent protein kinase PKA by the regulatory proteins of adeno-associated virus type 2. Mol. Cell. Biol. 18, 5921-5929.
6. Donsante, A., Miller, D.G., Li, Y., Vogler, C., Brunt, E.M., Russell, D.W., and Sands, M.S. (2007). AAV vector integration sites in mouse hepatocellular carcinoma. Science 317, 477.
7. Drew, H.R., Lockett, L.J., and Both, G.W. (2007). Increased complexity of wild-type adeno-associated virus-chromosomal junctions as determined by analysis of unselected cellular genomes. J. Gen. Virol. 88, 1722-1732.
8. Dyall, J., and Berns, K.I. (1998). Site-specific integration of adeno-associated virus into an episome with the target locus via a deletion-substitution mechanism. J. Virol. 72, 6195-6198.
9. Ehrhardt, C., Schmolke, M., Matzke, A., Knoblauch, A., Will, C., Wixler, V., and Ludwig, S. (2006). Polyethylenimine, a cost-effective transfection reagent. Signal Transduction 6, 179-184.
10. Feng, D., Chen, J., Yue, Y., Zhu, H., Xue, J., and Jia, W.W. (2006). A 16bp Rep binding element is sufficient for mediating Rep-dependent integration into AAVS1. J. Mol. Biol. 358, 38-45.
11. François, A., Guilbaud, M., Awedikian, R., Chadeuf, G., Moul-lier, P., and Salvetti, A. (2005). The cellular TATA binding protein is required for Rep-dependent replication of a minimal adeno-associated virus type 2 p5 element. J. Virol. 79, 11082-11094.
12. Hamilton, H., Gomos, J., Berns, K.I., and Falck-Pedersen, E. (2004). Adeno-associated virus site-specific integration and AAVS1 disruption. J. Virol. 78, 7874-7882.
13. Hermonat, P.L., Santin, A.D., and Batchu, R.B. (1996). The adeno-associated virus Rep78 major regulatory=transformation suppressor protein binds cellular Sp1 in vitro and evidence of a biological effect. Cancer Res. 56, 5299-5304.
14. Hermonat, P.L., Santin, A.D., Batchu, R.B., and Zhan, D. (1998). The adeno-associated virus Rep78 major regulatory protein binds the cellular TATA-binding protein in vitro and in vivo. Virology 245, 120-127.
15. Hickman, A.B., Ronning, D.R., Perez, Z.N., Kotin, R.M., and Dyda, F. (2004). The nuclease domain of adeno-associated virus Rep coordinates replication initiation using two distinct DNA recognition interfaces. Mol. Cell 13, 403-414.
16. Hoshijima, M., Ikeda, Y., Iwanaga, Y., Minamisawa, S., Date, M.O., Gu, Y., Iwatate, M., Li, M., Wang, L., Wilson, J.M., Wang, Y., Ross, J., Jr., and Chien, K.R. (2002). Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nat. Med. 8, 864-871.
17. Houbaviy, H.B., Usheva, A., Shenk, T., and Burley, S.K. (1996). Cocrystal structure of YY1 bound to the adeno-associated virus P5 initiator. Proc. Natl. Acad. Sci. U.S.A. 93, 13577-13582.
18. Huttner, N.A., Girod, A., Schnittger, S., Schoch, C., Hallek, M., and Buning, H. (2003). Analysis of site-specific transgene integration following cotransduction with recombinant adeno-associated virus and a Rep encoding plasmid. J. Gene Med. 5, 120-129.
19. Jurvansuu, J., Raj, K., Stasiak, A., and Beard, P. (2005). Viral transport of DNA damage that mimics a stalled replication fork. J. Virol. 79, 569-580.
20. Kotin, R.M., Siniscalco, M., Samulski, R.J., Zhu, X.D., Hunter, L., Laughlin, C.A., McLaughlin, S., Muzyczka, N., Rocchi, M., and Berns, K.I. (1990). Site-specific integration by ade-no-associated virus. Proc. Natl. Acad. Sci. U.S.A. 87, 2211-2215.
21. Kotin, R.M., Linden, R.M., and Berns, K.I. (1992). Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO J. 11, 5071-5078.
22. Kyostio, S.R., Owens, R.A., Weitzman, M.D., Antoni, B.A., Chejanovsky, N., and Carter, B.J. (1994). Analysis of adeno-associated virus (AAV) wild-type and mutant Rep proteins for their abilities to negatively regulate AAV p5 and p19 mRNA levels. J. Virol. 68, 2947-2957.
23. Linden, R.M., Ward, P., Giraud, C., Winocour, E., and Berns, K.I. (1996a). Site-specific integration by adeno-associated virus. Proc. Natl. Acad. Sci. U.S.A. 93, 11288-11294.
24. Linden, R.M., Winocour, E., and Berns, K.I. (1996b). The recombination signals for adeno-associated virus site-specific integration. Proc. Natl. Acad. Sci. U.S.A. 93, 7966-7972.
25. Manno, C.S., Pierce, G.F., Arruda, V.R., Glader, B., Ragni, M., Rasko, J.J., Ozelo, M.C., Hoots, K., Blatt, P., Konkle, B., Dake, M., Kaye, R., Razavi, M., Zajko, A., Zehnder, J., Rustagi, P.K., Nakai, H., Chew, A., Leonard, D., Wright, J.F., Lessard, R.R., Sommer, J.M., Tigges, M., Sabatino, D., Luk, A., Jiang, H., Mingozzi, F., Couto, L., Ertl, H.C., High, K.A., and Kay, M.A. (2006). Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat. Med. 12, 342-347.
26. McAlister, V.J., and Owens, R.A. (2007). Preferential integration of adeno-associated virus type 2 into a polypyrimidine= polypurine-rich region within AAVS1. J. Virol. 81, 9718-9726.
27. Murphy, M., Gomos-Klein, J., Stankic, M., and Falck-Pedersen, E. (2007). Adeno-associated virus type 2 p5 promoter: A Rep-regulated DNA switch element functioning in transcription, replication, and site-specific integration. J. Virol. 81, 3721-3730.
28. Philpott, N.J., Gomos, J., Berns, K.I., and Falck-Pedersen, E. (2002). A p5 integration efficiency element mediates Rep-dependent integration into AAVS1 at chromosome 19. Proc. Natl. Acad. Sci. U.S.A. 99, 12381-12385.
29. Ponnazhagan, S., Erikson, D., Kearns, W.G., Zhou, S.Z., Nahreini, P., Wang, X.S., and Srivastava, A. (1997). Lack of site-specific integration of the recombinant adeno-associated virus 2 genomes in human cells. Hum. Gene Ther. 8, 275-284.
30. Raj, K., Ogston, P., and Beard, P. (2001). Virus-mediated killing of cells that lack p53 activity. Nature 412, 914-917.
31. Rutledge, E.A., and Russell, D.W. (1997). Adeno-associated virus vector integration junctions. J. Virol. 71, 8429-8436.
32. Ryan, J.H., Zolotukhin, S., and Muzyczka, N. (1996). Sequence requirements for binding of Rep68 to the adeno-associated virus terminal repeats. J. Virol. 70, 1542-1553.
33. Samulski, R.J., Zhu, X., Xiao, X., Brook, J.D., Housman, D.E., Epstein, N., and Hunter, L.A. (1991). Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J. 10, 3941-3950.
34. Schmidt, M., Afione, S., and Kotin, R.M. (2000). Adeno-associated virus type 2 Rep78 induces apoptosis through caspase activation independently of p53. J. Virol. 74, 9441-9450.
35. Shelling, A.N., and Smith, M.G. (1994). Targeted integration of transfected and infected adeno-associated virus vectors containing the neomycin resistance gene. Gene Ther. 1, 165-169.
36. Trempe, J.P., and Carter, B.J. (1988). Regulation of adeno-associated virus gene expression in 293 cells: Control of mRNA abundance and translation. J. Virol. 62, 68-74.
37. Tsunoda, H., Hayakawa, T., Sakuragawa, N., and Koyama, H. (2000). Site-specific integration of adeno-associated virus-based plasmid vectors in lipofected HeLa cells. Virology 268, 391-401.
38. Usheva, A., and Shenk, T. (1996). YY1 transcriptional initiator: Protein interactions and association with a DNA site containing unpaired strands. Proc. Natl. Acad. Sci. U.S.A. 93, 13571-13576.
39. Weitzman, M.D., Kyostio, S.R., Kotin, R.M., and Owens, R.A. (1994). Adeno-associated virus (AAV) Rep proteins mediate, complex formation between AAV DNA and its integration site in human DNA. Proc. Natl. Acad. Sci. U.S.A. 91, 5808-5812.
40. Wonderling, R.S., and Owens, R.A. (1997). Binding sites for adeno-associated virus Rep proteins within the human genome. J. Virol. 71, 2528-2534.
41. Wu, J., Davis, M.D., and Owens, R.A. (2001). A Rep recognition sequence is necessary but not sufficient for nicking of DNA by adeno-associated virus type-2 Rep proteins. Arch. Biochem. Biophys. 389, 271-277.
42. Xu, Z.X., Chen, J.Z., Yue, Y.B., Zhang, J.Q., Li, Z.H., Feng, D.M., Ruan, Z.C., Tian, L., Xue, J.L., Wang, Q.J., and Jia, W. (2009). A 16-bp RBE element mediated Rep-dependent site-specific integration in AAVS1 transgenic mice for expression of hFIX. Gene Ther. 16, 589-595.
43. Yang, C.C., Xiao, X., Zhu, X., Ansardi, D.C., Epstein, N.D., Frey, M.R., Matera, A.G., and Samulski, R.J. (1997). Cellular recombination pathways and viral terminal repeat hairpin structures are sufficient for adeno-associated virus integration in vivo and in vitro. J. Virol. 71, 9231-9247.
44. Yang, Q., Chen, F., and Trempe, J.P. (1994). Characterization of cell lines that inducibly express the adeno-associated virus Rep proteins. J. Virol. 68, 4847-4856.
45. Young, S.M., Jr., and Samulski, R.J. (2001). Adeno-associated virus (AAV) site-specific recombination does not require a Rep-dependent origin of replication within the AAV terminal repeat. Proc. Natl. Acad. Sci. U.S.A. 98, 13525-13530.
46. Young, S.M., Jr., McCarty, D.M., Degtyareva, N., and Samulski, R.J. (2000). Roles of adeno-associated virus Rep protein and human chromosome 19 in site-specific recombination. J. Virol. 74, 3953-3966.
47. Zhang, C., Cortez, N.G., and Berns, K.I. (2007). Characterization of a bipartite recombinant adeno-associated viral vector for site-specific integration. Hum. Gene Ther. 18, 787-797.
48. Zhou, C., and Trempe, J.P. (1999). Induction of apoptosis by cadmium and the adeno-associated virus Rep proteins. Virology 261, 280-287.